Blood News and Research

RSS

Study offers new understanding of how the immune system reacts to COVID-19

Little has been known to date about how the immune system's natural killer (NK) cells detect which cells have been infected with SARS-CoV-2.

21 Feb 2022

Generic version of Viagra could be the long-waited remedy for dogs with megaesophagus

Sildenafil, the generic version of the drug known as Viagra, could be the long-waited remedy for a group of dogs with a rare disorder called megaesophagus.

21 Feb 2022

Mechanisms of IL-6 expression in peripheral monocyte-derived macrophages infected with SARS-CoV-2

Researchers examined the detailed mechanisms of ‘cytokine storm’ that induces ARDS, often resulting in the death of severely ill COVID-19 patients.

21 Feb 2022

HIV patient treated with blood stem cell transplant for leukemia achieves long-term remission

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine physician-scientists who performed the transplant and managed her care

21 Feb 2022

Treatment with direct-acting antivirals reduces emergency visits, hospitalizations among hepatitis C patients

Researchers at Henry Ford Health System, as part of a national hepatitis C collaborative, report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized or seek emergency care for liver and non-liver related health issues.

21 Feb 2022

High-fiber diet linked with reduced risk of developing dementia

We're always hearing that we should eat more fiber. It's known to be vitally important for a healthy digestive system and also has cardiovascular benefits like reduced cholesterol.

21 Feb 2022

Emergence of new HIV variant underscores importance of monitoring virus mutations

A new study published in the journal Science reported the presence of a subtype-B variant of HIV-1 with remarkably high virulence, circulating in the Netherlands during the past two decades.

20 Feb 2022

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

Researchers have developed a new vaccine candidate that is specifically targeted against the SARS-CoV-2 Omicron variant.

20 Feb 2022

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes.

18 Feb 2022

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer, with lower T-cell responses observed in patients with blood cancers.

18 Feb 2022

Music therapy is beneficial for patients with sickle cell disease

A new study from University Hospitals (UH) Connor Whole Health found patients with Sickle Cell Disease (SCD) who participated in music therapy learned new self-management skills and improved their ability to cope with pain.

18 Feb 2022

New class of molecules can correct cerebrovascular defects in brain pathologies

An impressive number of brain pathologies are closely linked to major cerebrovascular defects, which are currently impossible to treat due to a lack of drugs.

18 Feb 2022

Study identifies a protein complex critical for regulating apoptosis and necroptosis

Cell death plays an important role in normal human development and health but requires tightly orchestrated balance to avert disease. Too much can trigger a massive inflammatory immune response that damages tissues and organs. Not enough can interfere with the body's ability to fight infection or lead to cancer.

18 Feb 2022

PM2.5 reduction may have a beneficial effect on kidney function

mRNA vaccine-induced antibodies shown to be more effective in neutralizing SARS-CoV-2 and its variants than natural immunity

Researchers designed an electrochemiluminescence-based serology test with remarkable sensitivity to precisely quantify the amounts of anti-RBD antibodies in individuals infected with SARS-CoV-2.

18 Feb 2022

Blood News and Research

Study offers new understanding of how the immune system reacts to COVID-19

Generic version of Viagra could be the long-waited remedy for dogs with megaesophagus

Mechanisms of IL-6 expression in peripheral monocyte-derived macrophages infected with SARS-CoV-2

HIV patient treated with blood stem cell transplant for leukemia achieves long-term remission

Treatment with direct-acting antivirals reduces emergency visits, hospitalizations among hepatitis C patients

High-fiber diet linked with reduced risk of developing dementia

Emergence of new HIV variant underscores importance of monitoring virus mutations

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

Music therapy is beneficial for patients with sickle cell disease

New class of molecules can correct cerebrovascular defects in brain pathologies

Study identifies a protein complex critical for regulating apoptosis and necroptosis

PM2.5 reduction may have a beneficial effect on kidney function

Research provides a stronger connection between autoantibody formation and clotting in COVID-19

Two forms of heart bypass surgery provide similar patient outcomes, study reveals

Drugs that increase fetal hemoglobin levels may help people with sickle cell disease

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

Changes in the brain cortex of COVID-19 patients associated with inflammatory biomarkers

mRNA vaccine-induced antibodies shown to be more effective in neutralizing SARS-CoV-2 and its variants than natural immunity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News